Skip to Content
Merck
CN

SAB4200301

Monoclonal Anti-Leupaxin antibody produced in mouse

clone Leu133, tissue culture supernatant

Synonym(s):

Anti-LDPL, Anti-LPXN

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
Leu133, monoclonal
Application:
ICC, WB
Citations:
6
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

mouse

conjugate

unconjugated

antibody form

tissue culture supernatant

antibody product type

primary antibodies

clone

Leu133, monoclonal

form

buffered aqueous solution

mol wt

antigen ~43 kDa

species reactivity

monkey, human, mouse

technique(s)

immunocytochemistry: suitable, western blot: 1:8000-1:16,000 using human Ramos cell extracts

isotype

IgM

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... LPXN(9404)
mouse ... Lpxn(107321)

General description

Monoclonal Anti-Leupaxin (mouse IgM isotype) is derived from the hybridoma Leu133 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a peptide corresponding to a sequence at the N-terminus human Leupaxin conjugated to KLH. Leupaxin is a LIM (Lin11, Isl-1 and Mec-3) domain phosphotyrosine protein preferentially expressed in lymphoid tissues and hematopoietic cells. Leupaxin shares homology with the focal adhesion protein paxillin, in the LIM and LD (leucine/aspartate repeat) protein interaction domains. Leupaxin is expressed in cell types that lack FAK, such as human macrophages.

Immunogen

peptide corresponding to a sequence at the N-terminus human Leupaxin, conjugated to KLH. The corresponding sequence is identical in human leupaxin 1 and 2 isoforms.

Application

Monoclonal Anti-Leupaxin antibody produced in mouse has been used in immunoblotting and immunocytochemistry.

Biochem/physiol Actions

Leupaxin LIM domains have been shown to mediate localization to focal contacts and LD motifs have been implicated in focal adhesion kinase (FAK) and vinculin binding, resulting in the localization of FAK to focal adhesions. Leupaxin and protein tyrosine kinase 2 β (PYK2) are both preferentially expressed in leukocytes where they regulate cell type-specific signaling complex. Leupaxin can form a complex with PYK2 and PTP-PEST in several cell types including monocytes and osteoclasts and in prostate cancer cells. In osteoclasts, leupaxin has been suggested to be a critical nucleating component of the osteoclast podosomal signaling complex in the adhesion zone. Leupaxin is expressed in prostate cancer and is thought to play a role in adhesion and invasion of prostate carcinoma cells.

Physical form

Solution containing 15 mM sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Still not finding the right product?

Try our Product Selector Tool to narrow your options


Storage Class

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content


Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells
Sahu SN, et al.
American Journal of Physiology. Cell Physiology, 292(6), C2288-C2296 (2007)
Leupaxin binds to PEST domain tyrosine phosphatase PEP
Watanabe N, et al.
Molecular and Cellular Biochemistry, 269(1), 13-17 (2005)
Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression
Kaulfuss S, et al.
Oncogene, 28(45), 3971-3971 (2009)



Global Trade Item Number

SKUGTIN
SAB4200301-200UL04061837725319